Estrogenic activities of extracts of Chinese licorice (Glycyrrhiza uralensis) root in MCF-7 breast cancer cells

Journal of Steroid Biochemistry and Molecular Biology

Volumn 113, Issue 3-5, 2009, Pages 209-216

  Hu, Chunyan ^a   Liu, Huaqing ^b   Du, Juan ^a   Mo, Baoqing ^a   Qi, Hong ^a   Wang, Xinru ^a   Ye, Shengai ^c   Li, Zhong ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b BENGBU MEDICAL COLLEGE   (China)

^c THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Chinese licorice root; Estrogen receptor; Estrogenic activities; GREB1; MCF 7 cells; pS2

Indexed keywords

ACETIC ACID ETHYL ESTER; CYCLINE; ESTROGEN; ESTROGEN RECEPTOR ALPHA; GLYCYRRHIZA URALENSIS EXTRACT; HEXANE; MESSENGER RNA; METHANOL; PROTEIN GREB1; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER GROWTH; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; DRUG ACTIVITY; GENE TARGETING; GLYCYRRHIZA URALENSIS; HUMAN; HUMAN CELL; PLANT ROOT; UPREGULATION;

BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTROGEN RECEPTOR ALPHA; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; GLYCYRRHIZA URALENSIS; HUMANS; PHYTOESTROGENS; PLANT EXTRACTS; PLANT ROOTS; PROLIFERATING CELL NUCLEAR ANTIGEN; SOLVENTS;

GLYCYRRHIZA; GLYCYRRHIZA URALENSIS;

EID: 61349159851     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2008.12.019     Document Type: Article

References (39)

1. Wang Z.Y., and Nixon D.W. Licorice and cancer. Nutr. Cancer 39 (2001) 1-11
2. Demizu S., Kajiyama K., Takahashi K., Hiraga Y., Yamamoto S., Tamura Y., Okada K., and Kinoshita T. Antioxidant and antimicrobial constituents of licorice: isolation and structure elucidation of a new benzofuran derivative. Chem. Pharm. Bull. (Tokyo) 36 (1988) 3474-3479
3. Friis-Møller A., Chen M., Fuursted K., Christensen S.B., and Kharazmi A. In vitro antimycobacterial and antilegionella activity of licochalcone A from Chinese licorice roots. Planta Med. 68 (2002) 416-419
4. Vaya J., Belinky P.A., and Aviram M. Antioxidant constituents from licorice roots: isolation, structure elucidation and antioxidative capacity toward LDL oxidation. Free Radic. Biol. Med. 23 (1997) 302-313
5. Belinky P.A., Aviram M., Fuhrman B., Rosenblat M., and Vaya J. The antioxidative effects of the isoflavan glabridin on endogenous constituents of LDL during its oxidation. Atherosclerosis 137 (1998) 49-61
6. Leung A.Y. Encyclopedia of Common Natural Ingredients Used in Food, Drugs and Cosmetics (1980), Wiley, New York
7. Council of Europe. Flavouring Substances and Natural Sources of Flavourings. 3rd ed. (1981), Maisonneuve, Strasbourg
8. Tamir S., Eizenberg M., Somjen D., Stern N., Shelach R., Kaye A., and Vaya J. Estrogenic and antiproliferative properties of glabridin from licorice in human breast cancer cells. Cancer Res. 60 (2000) 5704-5709
9. Tamir S., Eizenberg M., Somjen D., Stern N., Shelach R., Kaye A., and Vaya J. Estrogen-like activity of glabrene and other constituents isolated from licorice root. J. Steroid Biochem. Mol. Biol. 78 (2001) 291-298
10. Maggiolini M., Statti G., Vivacqua A., Gabriele S., Rago V., Loizzo M., Menichini F., and Amdò S. Estrogenic and antiproliferative activities of isoliquiritigenin in MCF7 breast cancer cells. J. Steroid Biochem. Mol. Biol. 82 (2002) 315-322
11. Jo E.H., Hong H.D., Ahn N.C., Jung J.W., Yang S.R., Park J.S., Kim S.H., Lee Y.S., and Kang K.S. Modulations of the Bcl-2/Bax family were involved in the chemopreventive effects of licorice root (Glycyrrhiza uralensis Fisch) in MCF-7 human breast cancer cell. J. Agric. Food Chem. 52 (2004) 1715-1719
12. Somjen D., Katzburg S., Vaya J., Kaye A.M., Hendel D., Posner G.H., and Tamir S. Estrogenic activity of glabridin and glabrene from licorice roots on human osteoblasts and prepubertal rat skeletal tissues. J. Steroid Biochem. Mol. Biol. 91 (2004) 241-246
13. Jo E.H., Kim S.H., Ra J.C., Kim S.R., Cho S.D., Jung J.W., Yang S.R., Park J.S., Hwang J.W., Aruoma O.I., Kim T.Y., Lee Y.S., and Kang K.S. Chemopreventive properties of the ethanol extract of Chinese licorice (Glycyrrhiza uralensis) root: induction of apoptosis and G1 cell cycle arrest in MCF-7 human breast cancer cells. Cancer Lett. 230 (2005) 239-247
14. Hayashi H., Hattori S., Inoue K., Sarsenbaev K., Ito M., and Honda G. Field survey of glycyrrhiza plants in Central Asia (1) characterization of G. uralensis, G. glabra and the putative intermediate collected in Kazakhstan. Biol. Pharm. Bull. 26 (2003) 867-871
15. Aaltomaa S., Lipponen P., and Syrjänen K. Proliferating cell nuclear antigen (PCNA) immunolabeling as a prognostic factor in auxiliary lymph node negative breast cancer. Anticancer Res. 13 (1993) 533-538
16. Johnson D.G., and Walker C.L. Cyclins and cell cycle checkpoints. Annu. Rev. Pharmacol. Toxicol. 39 (1999) 295-312
17. Eisenberg D.M., Davis R.B., Ettner S.L., Appel S., Wilkey S., Van Rompay M., and Kessler R.C. Trends in alternative medicine use in the United States, 1990-1997. Results of a followup national survey. JAMA 280 (1998) 1569-1575
18. Rafi M.M., Rosen R.T., Vassil A., Ho C.T., Zhang H., Ghai G., Lambert G., and Di Paola R.S. Modulation of bcl-2 and cytotoxicity by licochalcone-A, a novel estrogenic flavonoid. Anticancer Res. 20 (2000) 2653-2658
19. Kanazawa M., Satomi Y., Mizutani Y., Ukimura O., Kawauchi A., Sakai T., Baba M., Okuyama T., Nishino H., and Miki T. Isoliquiritigenin inhibits the growth of prostate cancer. Eur. Urol. 43 (2003) 580-586
20. Amato P., Christophe S., and Mellon P.L. Estrogenic activity of herbs commonly used as remedies for menopausal symptoms. Menopause 9 (2002) 145-150
21. Zava D.T., Blen M., and Duwe G. Estrogenic activity of natural and synthetic estrogens in human breast cancer cells in culture. Environ. Health Prospect. 105 (1997) 637-645
22. Shao Z.M., Wu J., Shen Z.Z., and Barsky S.H. Genistein exerts multiple suppressive effects on human breast carcinoma cells. Cancer Res. 58 (1998) 4851-4857
23. Markovits J., Linassier C., Fossé P., Couprie J., Pierre J., Jacquemin-Sablon A., Saucier J.M., Le Pecq J.B., and Larsen A.K. Inhibitory effects of the tyrosine kinase inhibitor genistein on mammalian DNA topoisomerase II. Cancer Res. 49 (1989) 5111-5117
24. Labrecque L., Lamy S., Chapus A., Mihoubi S., Durocher Y., Cass B., Bojanowski M.W., Gingras D., and Béliveau R. Genistein, a dietary-derived inhibitor of in vivo angiogenesis. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 2690-2694
25. Tachibana K.E., Gonzalez M.A., and Coleman N. Cell-cycle-dependent regulation of DNA replication and its relevance to cancer pathology. J. Pathol. 205 (2005) 123-129
26. Thornberry N., and Lazebnik Y. Caspases: enemies within. Science 281 (1998) 1312-1316
27. Nawaz Z., Lonard D.M., Dennis A.P., Smith C.L., and O'Malley B.W. Proteasome-dependent degradation of the human estrogen receptor. Proc. Natl. Acad. Sci. U.S.A 96 (1999) 1858-1862
28. Barchiesi F., Jackson E.K., Imthurn B., Fingerle J., Gillespie D.G., and Dubey R.K. Differential regulation of estrogen receptor subtypes alpha and beta in human aortic smooth muscle cells by oligonucleotides and estradiol. J. Clin. Endocrinol. Metab. 89 (2004) 2373-2381
29. Tschugguel W., Dietrich W., Zhegu Z., Stonek F., Kolbus A., and Huber J.C. Differential regulation of proteasome-dependent estrogen receptor alpha and beta turnover in cultured human uterine artery endothelial cells. J. Clin. Endocrinol. Metab. 88 (2003) 2281-2287
30. Dowsett M., and Ashworth A. New biology of the oestrogen receptor. Lancet 362 (2003) 260-262
31. Reid G., Hübner M.R., Metivier R., Brand H., Denger S., Manu D., Beaudouin J., Ellenberg J., and Gannon F. Cyclic, proteasome mediated turnover of unliganded and liganded ERalpha on responsive promoters is an integral feature of estrogen signaling. Mol. Cell 11 (2003) 695-707
32. Brown A.M., Jeltsch J.M., Roberts M., and Chambon P. Activation of pS2 gene transcription is a primary response to estrogen in the human breast cancer cell line MCF-7. Proc. Natl. Acad. Sci. U.S.A. 81 (1984) 6344-6348
33. Foekens J.A., Portengen H., Look M.P., Putten W.L., Thirion B., Bontenbal M., and Klijn J.G. Relationship of PS2 with response to tamoxifen therapy in patients with recurrent breast cancer. Br. J. Cancer 70 (1994) 1217-1223
34. Henry J.A., Piggott N.H., Mallick U.K., Nicholson S., Farndon J.R., Westley B.R., and May F.E. pNR-2/pS2 immunohistochemical staining in breast cancer: correlation with prognostic factors and endocrine response. Br. J. Cancer 63 (1991) 615-622
35. Nagase T., Ishikawa K., Miyajima N., Tanaka A., Kotani H., Nomura N., and Ohara O. Prediction of the coding sequences of unidentified human genes. IX. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro. DNA Res. 5 (1998) 31-39
36. Ghosh M.G., Thompson D.A., and Weigel R.J. PDZK1 and GREB1 are estrogen-regulated genes expressed in hormone-responsive breast cancer. Cancer Res. 60 (2000) 6367-6375
37. Rae J.M., Johnson M.D., Scheys J.O., Cordero K.E., Larios J.M., and Lippman M.E. GREB1 is a critical regulator of hormone dependent breast cancer growth. Breast Cancer Res. Treat. 92 16 (2005) 141-149
38. Hansen R.K., Oesterreich S., Lemieux P., Sarge K.D., and Fuqua S.A. Quercetin inhibits heat shock protein induction but not heat shock factor DNA-binding in human breast carcinoma cells. Biochem. Biophys. Res. Commun. 239 (1997) 851-856
39. Walker E.H., Pacold M.E., Perisic O., Stephens L., Hawkins P.T., Wymann M.P., and Williams R.L. Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY, 294002, quercetin, myricetin, and staurosporine. Mol. Cell 6 (2000) 909-919